Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.2817
-0.0007 (-0.25%)
At close: Jan 9, 2026, 4:00 PM EST
0.2979
+0.0162 (5.75%)
After-hours: Jan 9, 2026, 7:53 PM EST
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $12.9 million as of January 9, 2026. Its market cap has decreased by -48.72% in one year.
Market Cap
12.90M
Enterprise Value
12.63M
1-Year Change
-48.72%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $12.90M, a decrease of -95.58%. That is a compound annual growth rate of -26.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 12.90M | -2.53% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |